Baillie Gifford & CO Quanterix Corp Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
A detailed history of Baillie Gifford & CO transactions in Quanterix Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 633,001 shares of QTRX stock, worth $6.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
633,001
Previous 633,460
0.07%
Holding current value
$6.06 Million
Previous $8.37 Million
2.04%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding QTRX
# of Institutions
158Shares Held
33.2MCall Options Held
30.6KPut Options Held
25.1K-
Alliancebernstein L.P. New York, NY3.27MShares$31.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$30 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA2.52MShares$24.1 Million2.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.2MShares$21 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.06MShares$19.7 Million0.01% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $354M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...